CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc., a clinical stage drug development company built on a pathway pharmacology technology platform, today announced that CAT-1004 will be featured in an oral presentation and a poster presentation at the upcoming Muscular Dystrophy Association Scientific Conference. The Muscular Dystrophy Association Scientific Conference will be held March 11-14, 2015, in Washington, DC.
Help employers find you! Check out all the jobs and post your resume.
